Endovascular treatment of extracranial atherosclerotic disease involving the vertebral artery origins: A comparison of drug-eluting and bare-metal stents

Karthikram Raghuram, Carl Seynnaeve, Ansaar T. Rai

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: To determine whether drug-eluting (DE) stents offer any advantage over bare-metal (BM) stents in terms of restenosis rates and to identify indications for vertebral artery stenting (VAS) based on the current literature. Methodology: A retrospective analysis was performed for patients who underwent extracranial VAS for symptomatic stenosis. Patients were divided into two groups based on stent use (DE and BM). Results: A total of 28 stents were implanted in 24 patients. Of these, 13 were DE and 15 BM. Technical success was achieved in all patients. There were procedure-related complications of retroperitoneal hematoma in some patients (3.6%). The median clinical and imaging follow-up times were 26 and 21 months, respectively, for the BM arm and 13 and 12 months, respectively, for the DE group. The mean stenosis percentage was 80.7±10.9 for the BM group and 87.0±9.5 for the DE group. The mean stent diameter was 4.7±0.5 for the BM group and 3.3±0.4 for the DE group (p

Original languageEnglish (US)
Pages (from-to)206-210
Number of pages5
JournalJournal of NeuroInterventional Surgery
Volume4
Issue number3
DOIs
StatePublished - May 2012
Externally publishedYes

Fingerprint

Vertebral Artery
Stents
Metals
Pharmaceutical Preparations
Drug-Eluting Stents
Pathologic Constriction
Therapeutics
Hematoma

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

@article{1f4a874c76974427933cc837abea5be9,
title = "Endovascular treatment of extracranial atherosclerotic disease involving the vertebral artery origins: A comparison of drug-eluting and bare-metal stents",
abstract = "Objective: To determine whether drug-eluting (DE) stents offer any advantage over bare-metal (BM) stents in terms of restenosis rates and to identify indications for vertebral artery stenting (VAS) based on the current literature. Methodology: A retrospective analysis was performed for patients who underwent extracranial VAS for symptomatic stenosis. Patients were divided into two groups based on stent use (DE and BM). Results: A total of 28 stents were implanted in 24 patients. Of these, 13 were DE and 15 BM. Technical success was achieved in all patients. There were procedure-related complications of retroperitoneal hematoma in some patients (3.6{\%}). The median clinical and imaging follow-up times were 26 and 21 months, respectively, for the BM arm and 13 and 12 months, respectively, for the DE group. The mean stenosis percentage was 80.7±10.9 for the BM group and 87.0±9.5 for the DE group. The mean stent diameter was 4.7±0.5 for the BM group and 3.3±0.4 for the DE group (p",
author = "Karthikram Raghuram and Carl Seynnaeve and Rai, {Ansaar T.}",
year = "2012",
month = "5",
doi = "10.1136/neurintsurg-2011-010051",
language = "English (US)",
volume = "4",
pages = "206--210",
journal = "Journal of NeuroInterventional Surgery",
issn = "1759-8478",
publisher = "BMJ Publishing Group",
number = "3",

}

TY - JOUR

T1 - Endovascular treatment of extracranial atherosclerotic disease involving the vertebral artery origins

T2 - A comparison of drug-eluting and bare-metal stents

AU - Raghuram, Karthikram

AU - Seynnaeve, Carl

AU - Rai, Ansaar T.

PY - 2012/5

Y1 - 2012/5

N2 - Objective: To determine whether drug-eluting (DE) stents offer any advantage over bare-metal (BM) stents in terms of restenosis rates and to identify indications for vertebral artery stenting (VAS) based on the current literature. Methodology: A retrospective analysis was performed for patients who underwent extracranial VAS for symptomatic stenosis. Patients were divided into two groups based on stent use (DE and BM). Results: A total of 28 stents were implanted in 24 patients. Of these, 13 were DE and 15 BM. Technical success was achieved in all patients. There were procedure-related complications of retroperitoneal hematoma in some patients (3.6%). The median clinical and imaging follow-up times were 26 and 21 months, respectively, for the BM arm and 13 and 12 months, respectively, for the DE group. The mean stenosis percentage was 80.7±10.9 for the BM group and 87.0±9.5 for the DE group. The mean stent diameter was 4.7±0.5 for the BM group and 3.3±0.4 for the DE group (p

AB - Objective: To determine whether drug-eluting (DE) stents offer any advantage over bare-metal (BM) stents in terms of restenosis rates and to identify indications for vertebral artery stenting (VAS) based on the current literature. Methodology: A retrospective analysis was performed for patients who underwent extracranial VAS for symptomatic stenosis. Patients were divided into two groups based on stent use (DE and BM). Results: A total of 28 stents were implanted in 24 patients. Of these, 13 were DE and 15 BM. Technical success was achieved in all patients. There were procedure-related complications of retroperitoneal hematoma in some patients (3.6%). The median clinical and imaging follow-up times were 26 and 21 months, respectively, for the BM arm and 13 and 12 months, respectively, for the DE group. The mean stenosis percentage was 80.7±10.9 for the BM group and 87.0±9.5 for the DE group. The mean stent diameter was 4.7±0.5 for the BM group and 3.3±0.4 for the DE group (p

UR - http://www.scopus.com/inward/record.url?scp=84860779535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860779535&partnerID=8YFLogxK

U2 - 10.1136/neurintsurg-2011-010051

DO - 10.1136/neurintsurg-2011-010051

M3 - Article

C2 - 21990510

AN - SCOPUS:84860779535

VL - 4

SP - 206

EP - 210

JO - Journal of NeuroInterventional Surgery

JF - Journal of NeuroInterventional Surgery

SN - 1759-8478

IS - 3

ER -